Aier Eye Hospital Group Co., Ltd. (SHE:300015)

China flag China · Delayed Price · Currency is CNY
11.08
+0.20 (1.84%)
Apr 28, 2026, 3:13 PM CST
-15.48%
Market Cap 102.98B
Revenue (ttm) 22.72B
Net Income (ttm) 3.37B
Shares Out 9.29B
EPS (ttm) 0.36
PE Ratio 30.48
Forward PE 24.90
Dividend 0.20 (1.84%)
Ex-Dividend Date Jan 15, 2026
Volume 172,717,811
Average Volume 87,537,361
Open 10.25
Previous Close 10.88
Day's Range 10.25 - 11.18
52-Week Range 9.32 - 13.95
Beta 0.52
RSI 72.41
Earnings Date Apr 24, 2026

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China. [Read more]

Sector Healthcare
Founded 2002
Employees 42,817
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300015
Full Company Profile

Financial Performance

In 2025, Aier Eye Hospital Group's revenue was 22.35 billion, an increase of 6.53% compared to the previous year's 20.98 billion. Earnings were 3.24 billion, a decrease of -8.88%.

Financial Statements

News

There is no news available yet.